Xeriant, Inc.: Form 10-Q for the period ended Dec 31, 2025
Filed with the SEC on Feb 17, 2026 and accepted by EDGAR at Feb 17, 2026, 16:35 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2025-10-01 to 2025-12-31 | $16.3k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2025-07-01 to 2025-12-31 | $70.3k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-10-01 to 2025-12-31 | −$231.1k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2025-07-01 to 2025-12-31 | −$535.1k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-10-01 to 2025-12-31 | $35.8k | us-gaap:InterestExpense |
| Interest expense | 6 months2025-07-01 to 2025-12-31 | $80.6k | us-gaap:InterestExpense |
| Income tax | 3 months2025-10-01 to 2025-12-31 | −$15.9k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2025-07-01 to 2025-12-31 | $108.7k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-10-01 to 2025-12-31 | −$297.6k | us-gaap:NetIncomeLoss |
| Net income | 6 months2025-07-01 to 2025-12-31 | $1.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-10-01 to 2025-12-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2025-07-01 to 2025-12-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-10-01 to 2025-12-31 | $0.00 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2025-07-01 to 2025-12-31 | $0.00 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-10-01 to 2025-12-31 | 779,770,035 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2025-07-01 to 2025-12-31 | 1,701,389,294 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2025-07-01 to 2025-12-31 | −$383.3k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Current assets | At period end2025-12-31 | $94.9k | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $103.4k | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $5.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $5.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-12-31 | −$2.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001477932-26-000862. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.